J&J | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
AbbVie USD 5.18B 349M 2025-03
Abbott USD 6.53B 1.08B 2025-03
Amgen USD 8.81B 3.16B 2025-03
AstraZeneca USD 5.23B 258M 2025-03
Baxter International USD 2.29B 530M 2025-03
Bayer EUR 4.02B 2.18B 2025-03
Becton, Dickinson and Co. USD 667M 44M 2025-03
Biogen USD 2.6B 223.3M 2025-03
Boston Scientific USD 725M 311M 2025-03
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
CONMED USD 35.48M 11.03M 2025-03
Cooper Companies USD 116.2M 15.3M 2025-04
Dexcom USD 904.9M 298.8M 2025-03
Edwards Lifesciences USD 3.14B 95.4M 2025-03
Eli Lilly USD 3.09B 175.1M 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
GlaxoSmithKline GBP 4.46B 594M 2025-03
Globus Medical USD 461.27M 323.17M 2025-03
Hologic USD 1.43B 352.6M 2025-03
Insulet USD 1.01B 194.6M 2025-03
Integra LifeSciences USD 239.1M 7.27M 2025-03
Intuitive Surgical USD 9.53B 431.3M 2025-06
J&J USD 38.47B 32.35B 2025-03
Medtronic USD 2.22B 978M 2025-04
Merck USD 8.63B 4.61B 2025-03
Merit Medical Systems USD 395.53M 18.81M 2025-03
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.43B 387M 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Stryker USD 2.32B 1.33B 2025-03
Tandem Diabetes Care USD 53.57M 15.66M 2025-03
Teva Pharmaceutical Industries USD 1.7B 1.6B 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Zimmer Biomet Holdings USD 525.5M 43.5M 2024-12
Zoetis USD 1.72B 264M 2025-03


J&J Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.